Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001948271 | SCV002201240 | uncertain significance | Nemaline myopathy 6 | 2023-07-05 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. This variant has not been reported in the literature in individuals affected with KBTBD13-related conditions. This variant is present in population databases (rs770027984, gnomAD 0.002%). This sequence change creates a premature translational stop signal (p.Thr251Serfs*150) in the KBTBD13 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 208 amino acid(s) of the KBTBD13 protein. |